Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
WHAT IS LIPOHYDROXY ACID
Potential treatment for polymorphic light eruption A 2010 phase III, randomized, double blind, placebo controlled, parallel group study was undertaken in Germany, the Netherlands, and Belgium to evaluate the safety and efficacy of subcutaneous implants of melanotan I (16 mg) in patients suffering from polymorphic light eruption (PLE), a condition characterized by a rash following exposure to sunlight
Apply toner if available
Biochem J 356: 799804
We additionally thank the Cambridge Institute for Medical Research (CIMR) Microscopy Facility for their support with acquiring the splitFAST imaging data
